ATE227980T1 - Zubereitung mit verzögerter freisetzung und deren herstellung - Google Patents
Zubereitung mit verzögerter freisetzung und deren herstellungInfo
- Publication number
- ATE227980T1 ATE227980T1 AT97908520T AT97908520T ATE227980T1 AT E227980 T1 ATE227980 T1 AT E227980T1 AT 97908520 T AT97908520 T AT 97908520T AT 97908520 T AT97908520 T AT 97908520T AT E227980 T1 ATE227980 T1 AT E227980T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- release preparation
- sustained release
- sustained
- dispersing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7301696 | 1996-03-28 | ||
| PCT/JP1997/001041 WO1997035563A2 (en) | 1996-03-28 | 1997-03-27 | Sustained-release preparation and its production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE227980T1 true ATE227980T1 (de) | 2002-12-15 |
Family
ID=13506129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97908520T ATE227980T1 (de) | 1996-03-28 | 1997-03-27 | Zubereitung mit verzögerter freisetzung und deren herstellung |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6190702B1 (de) |
| EP (1) | EP0889722B1 (de) |
| AT (1) | ATE227980T1 (de) |
| AU (1) | AU2043297A (de) |
| CA (1) | CA2241322C (de) |
| DE (1) | DE69717263T2 (de) |
| DK (1) | DK0889722T3 (de) |
| WO (1) | WO1997035563A2 (de) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6270795B1 (en) | 1995-11-09 | 2001-08-07 | Microbiological Research Authority | Method of making microencapsulated DNA for vaccination and gene therapy |
| EP0965336A1 (de) | 1995-11-09 | 1999-12-22 | Microbiological Research Authority | Mikroverkapselte DNA zur Gentherapie |
| US6287587B2 (en) | 1997-07-15 | 2001-09-11 | Takeda Chemical Industries, Ltd. | Process for producing sustained-release preparation by in-water drying |
| NZ505651A (en) | 1998-01-16 | 2003-08-29 | Takeda Chemical Industries Ltd | Sustained release composition comprising biologically active substance, hydroxynaphthoic acid and biodegradable polymer |
| DE69906254T2 (de) * | 1998-01-21 | 2003-11-13 | Takeda Chemical Industries, Ltd. | Verfahren zur gerfriertrocknung von präparaten mit verzörgerter wirkstoffabgabe |
| CA2324568A1 (en) | 1998-03-20 | 1999-09-30 | Takeda Chemical Industries, Ltd. | Sustained-release preparation of physiologically active polypeptide and production thereof |
| GB9810236D0 (en) | 1998-05-13 | 1998-07-08 | Microbiological Res Authority | Improvements relating to encapsulation of bioactive agents |
| JP2003519651A (ja) * | 2000-01-14 | 2003-06-24 | ブラウン ユニバーシティ リサーチ ファウンデーション | 微紛化凍結乾燥粒子 |
| US7029700B2 (en) | 2000-01-14 | 2006-04-18 | Brown University Research Foundation | Micronized freeze-dried particles |
| AU4935701A (en) | 2000-03-24 | 2001-10-08 | Genentech Inc | Use of insulin for the treatment of cartilagenous disorders |
| US20080233165A1 (en) * | 2000-08-07 | 2008-09-25 | Biolok International, Inc. | Time release calcium sulfate and growth factor matrix for bone augmentation |
| US7488761B2 (en) * | 2000-08-07 | 2009-02-10 | Orthogen Llc | Polymer containing calcium sulfate particles for bone augmentation |
| US6824822B2 (en) * | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
| EP1356809A4 (de) * | 2000-12-28 | 2008-05-14 | Takeda Pharmaceutical | Retardzubereitungen |
| JP2002265383A (ja) * | 2001-03-14 | 2002-09-18 | Mitsubishi Pharma Corp | インターフェロンα注射用液状製剤 |
| WO2002078673A1 (fr) * | 2001-03-29 | 2002-10-10 | Takeda Chemical Industries, Ltd. | Procede de production d'un medicament sous forme de granules fins |
| US20040126900A1 (en) * | 2001-04-13 | 2004-07-01 | Barry Stephen E | High affinity peptide- containing nanoparticles |
| US6887897B2 (en) | 2001-07-31 | 2005-05-03 | Mission Pharmacal Company | Calcium glutarate supplement and phosphorus binder |
| CN1620285A (zh) * | 2001-12-26 | 2005-05-25 | 武田药品工业株式会社 | 新微球和其生产方法 |
| DK1551876T3 (da) | 2002-10-16 | 2011-06-14 | Purdue Pharma Lp | Antistoffer, der binder til celle-associerede ca 125/0722P og fremgangsmåder til anvendelse deraf |
| AU2003282955A1 (en) * | 2002-10-17 | 2004-05-04 | Alkermes Controlled Therapeutics, Inc. Ii | Microencapsulation and sustained release of biologically active polypeptides |
| US7456254B2 (en) * | 2004-04-15 | 2008-11-25 | Alkermes, Inc. | Polymer-based sustained release device |
| US20060110423A1 (en) * | 2004-04-15 | 2006-05-25 | Wright Steven G | Polymer-based sustained release device |
| CN1968700A (zh) * | 2004-04-15 | 2007-05-23 | 阿尔克姆斯有限公司 | 聚合物基的持续释放装置 |
| US20070219131A1 (en) * | 2004-04-15 | 2007-09-20 | Ben-Sasson Shmuel A | Compositions capable of facilitating penetration across a biological barrier |
| US8075910B2 (en) * | 2004-05-20 | 2011-12-13 | Pbm Pharmaceuticals, Inc. | Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| DE102005017777A1 (de) * | 2005-04-13 | 2006-10-19 | Pharmasol Gmbh | Verfahren zur schonenden Herstellung von hochfeinen Partikelsuspensionen |
| ES2338039T3 (es) * | 2005-04-13 | 2010-05-03 | ABBOTT GMBH & CO. KG | Procedimiento para la obtencion cuidadosa de supensiones de particulas de elevada finura y particulas de elevada finura, asi como su aplicacion. |
| PL2359808T3 (pl) | 2006-08-09 | 2013-10-31 | Intarcia Therapeutics Inc | Osmotyczne systemy dostawcze i zespoły tłokowe |
| WO2008118712A1 (en) * | 2007-03-22 | 2008-10-02 | Alkermes, Inc. | Coacervation process |
| EP2157967B1 (de) | 2007-04-23 | 2013-01-16 | Intarcia Therapeutics, Inc | Suspensionsformulierungen insulinotroper peptide und ihre verwendung |
| US20080317865A1 (en) * | 2007-06-20 | 2008-12-25 | Alkermes, Inc. | Quench liquids and washing systems for production of microparticles |
| EP2044934A1 (de) | 2007-10-01 | 2009-04-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Dispersion von Poloxamer-Proteinpartikeln, Herstellungsmethoden und Verwendung davon |
| EP2240155B1 (de) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe |
| EP3685837A1 (de) * | 2008-09-04 | 2020-07-29 | Amylin Pharmaceuticals, LLC | Formulierungen mit verzögerter freisetzung unter verwendung nichtwässriger träger |
| RU2678833C2 (ru) | 2008-09-17 | 2019-02-04 | Киазма Инк. | Фармацевтические композиции и соответствующие способы доставки |
| EP3323423B1 (de) | 2009-09-28 | 2020-06-17 | Intarcia Therapeutics, Inc | Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| SI3253401T1 (sl) | 2015-02-03 | 2025-07-31 | Amryt Endo, Inc. | Zdravljenje akromegalije z oralnim oktreotidom |
| ES2968262T3 (es) | 2015-06-03 | 2024-05-08 | I2O Therapeutics Inc | Sistemas de colocación de implantes |
| KR20240037175A (ko) | 2016-05-16 | 2024-03-21 | 인타르시아 세라퓨틱스 인코포레이티드 | 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법 |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| AU2018206539A1 (en) | 2017-01-03 | 2019-07-18 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
| DK4218738T3 (da) | 2017-02-24 | 2024-11-11 | Univ California | Partikeldråbestrukturer og fremgangsmåder til fremstilling og anvendelse af disse |
| US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
| US20250264477A1 (en) | 2021-04-14 | 2025-08-21 | Partillion Bioscience Corporation | Nanoscale reaction chambers and methods of using the same |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5385738A (en) | 1983-10-14 | 1995-01-31 | Sumitomo Pharmaceuticals Company, Ltd. | Sustained-release injection |
| US4774091A (en) | 1983-10-14 | 1988-09-27 | Sumitomo Pharmaceuticals Company, Ltd. | Long-term sustained-release preparation |
| US4963367A (en) | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
| US4962091A (en) | 1986-05-23 | 1990-10-09 | Syntex (U.S.A.) Inc. | Controlled release of macromolecular polypeptides |
| JP3116311B2 (ja) | 1990-06-13 | 2000-12-11 | エーザイ株式会社 | マイクロスフィアの製法 |
| NZ240214A (en) * | 1990-10-16 | 1993-02-25 | Takeda Chemical Industries Ltd | Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs |
| US5288502A (en) | 1991-10-16 | 1994-02-22 | The University Of Texas System | Preparation and uses of multi-phase microspheres |
| JPH08503950A (ja) | 1992-12-02 | 1996-04-30 | アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド | 徐放性成長ホルモン含有マイクロスフェア |
| DK0686045T3 (da) | 1993-02-23 | 2001-03-05 | Genentech Inc | Stabilisering af med organisk opløsningsmiddel behandlede polypeptider med et hjælpestof |
| NZ260909A (en) | 1993-07-05 | 1995-04-27 | Takeda Chemical Industries Ltd | Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution |
| WO1995011009A1 (en) | 1993-10-22 | 1995-04-27 | Genentech, Inc. | Method for preparing microspheres comprising a fluidized bed drying step |
| US6117455A (en) * | 1994-09-30 | 2000-09-12 | Takeda Chemical Industries, Ltd. | Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent |
| TW448055B (en) * | 1995-09-04 | 2001-08-01 | Takeda Chemical Industries Ltd | Method of production of sustained-release preparation |
| EP0765660A3 (de) * | 1995-09-28 | 1998-09-23 | Takeda Chemical Industries, Ltd. | Mikrokapseln enthaltend 2-Piperazinon-1-essigsäure Verbindungen |
-
1997
- 1997-03-27 US US08/849,172 patent/US6190702B1/en not_active Expired - Lifetime
- 1997-03-27 AU AU20432/97A patent/AU2043297A/en not_active Abandoned
- 1997-03-27 AT AT97908520T patent/ATE227980T1/de not_active IP Right Cessation
- 1997-03-27 DE DE69717263T patent/DE69717263T2/de not_active Expired - Lifetime
- 1997-03-27 WO PCT/JP1997/001041 patent/WO1997035563A2/en not_active Ceased
- 1997-03-27 EP EP97908520A patent/EP0889722B1/de not_active Expired - Lifetime
- 1997-03-27 CA CA002241322A patent/CA2241322C/en not_active Expired - Fee Related
- 1997-03-27 DK DK97908520T patent/DK0889722T3/da active
-
2001
- 2001-01-19 US US09/764,052 patent/US20010006678A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20010006678A1 (en) | 2001-07-05 |
| DE69717263T2 (de) | 2003-07-24 |
| WO1997035563A3 (en) | 1997-11-20 |
| DE69717263D1 (de) | 2003-01-02 |
| EP0889722A2 (de) | 1999-01-13 |
| AU2043297A (en) | 1997-10-17 |
| CA2241322C (en) | 2009-01-13 |
| CA2241322A1 (en) | 1997-10-02 |
| EP0889722B1 (de) | 2002-11-20 |
| WO1997035563A2 (en) | 1997-10-02 |
| US6190702B1 (en) | 2001-02-20 |
| DK0889722T3 (da) | 2003-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69717263D1 (de) | Zubereitung mit verzögerter freisetzung und deren herstellung | |
| DE60106666D1 (de) | Kontinuierlicher Prozess für die Herstellung von Mikrokapseln mit verzögerten Freisetzung von wasserlöslichen Peptiden | |
| AU2001236905A1 (en) | Bioadhesive composition | |
| HUP9600647A3 (en) | Phosphono-monoester-nucleinic acids, process for producing them, and their use | |
| DE69613095D1 (de) | Intelligentes CAD-Verfahren, das Leistungswerte von Produkten miteinbezieht | |
| ATE196457T1 (de) | Verfahren zur herstellung von halogenierten alkanen | |
| PT709034E (pt) | Processo para o fabrico de um agente de textura para produtos lacteos | |
| ATE149527T1 (de) | Modifizierte polydextrose und deren herstellung | |
| CA2032278A1 (en) | Multistep synthesis of hexafluoropropylene | |
| DE69729312D1 (de) | Mikropartikel mit gesteuerter Freisetzung | |
| PL326081A1 (en) | Novel derivatives of amino acids, their production and application | |
| IL88370A0 (en) | Process for the production of biodegradable microcapsules of water-soluble peptides and proteins,and microcapsules obtained by this process | |
| EP0162465A3 (de) | Verbindungen verwendet in Parfüms | |
| CA2025678A1 (en) | Natural delta-lactones and process of the production thereof | |
| EP0425680A4 (en) | New vitamin b 12? derivative, production thereof, and application thereof | |
| PL325398A1 (en) | Novel derivatives of carboxylic acids, their production and application | |
| FR2760644B1 (fr) | Composition a base de collagene, son procede de preparation et ses applications | |
| AU7948694A (en) | Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation | |
| MX9102624A (es) | Composicion de shampoo acondicionador y proceso para su produccion. | |
| CA2098277A1 (en) | Preparation of formyltetrahydropyrans | |
| IT1293123B1 (it) | Metodo per la produzione di manufatti floccati e decorati, attrezzatura per detta produzione e manufatti cosi' realizzati. | |
| DE68906563D1 (de) | 2(1-alkylaminoalkyl)-3-hydroxy-1,4-naphthoquinon.verfahren zur herstellung und verfahren zur herstellung daraus von 2-(1-alkenyl)-3-hydroxy-1,4-naphthochinon und 2-alkyl-3-acyloxy-1,4 naphthochinon. | |
| ITRM920878A0 (it) | Procedimento per ottenere statuine per presepi, immagini, statuine decorative e simili. | |
| ATE205210T1 (de) | 2-azabicyclo(2.2.1)heptan-derivate, ihre herstellung und ihre anwendung | |
| RU92016202A (ru) | Способ получения непредельных амидов, способ получения пестицидной композиции на их основе, использование амидов, пестицидная композиция и сами непредельные амиды |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |